Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kedaung Indah Can Tbk (KICI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance

Kedaung Indah Can TbkTrade
Organon Pharma Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Kedaung Indah Can Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Kedaung Indah Can Tbk trades at Rp280 (market cap 76.18B, 5.57M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Organon Pharma Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

KICISCPI
Market Cap
76.18B104.4B
Volume
5.57M
Lot
55.72K
Turnover
1.56B
Average Price
280.55
Value
1.56B
Indicative Equilibrium Price
280
Indicative Equilibrium Volume
6.24K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

KICI
View details
SCPI
View details

About Kedaung Indah Can Tbk

PT Kedaung Indah Can Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970, based on Notarial Deed No. 37, dated January 11, 1974 of Julian Nimrod Siregar Gelar Mangaradja Namora, S.H., notary in Jakarta. The Company produces Cans and Enamel kitchenware. The company`s products have been exported since 1988, mostly to US, Saudi Arabia, and Japan, an also to Europe and South America.

Read more on KICI

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI